5-HT1A and 5-HT1B receptors control the firing of serotoninergic neurons in the dorsal raphe nucleus of the mouse:: studies in 5-HT1B knock-out mice

被引:75
作者
Evrard, A
Laporte, AM
Chastanet, M
Hen, R
Hamon, M
Adrien, J
机构
[1] Univ Paris 06, INSERM, U288, F-75634 Paris 13, France
[2] Columbia Univ P&S, Ctr Neurobiol & Behav, New York, NY 10032 USA
关键词
5-HT1B ligands; dorsal raphe nucleus; electrophysiology; mouse; serotonin;
D O I
10.1046/j.1460-9568.1999.00800.x
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
The characteristics of the spontaneous firing of serotoninergic neurons in the dorsal raphe nucleus and its control by serotonin (5-hydroxytryptamine, 5-HT) receptors were investigated in wild-type and 5-HT1B knock-out (5-HT1B-/-) mice of the 129/Sv strain, anaesthetized with chloral hydrate. In both groups of mice, 5-HT neurons exhibited a regular activity with an identical firing rate of 0.5-4.5spikes/s. Intravenous administration of the 5-HT reuptake inhibitor citalopram or the 5-HT1A agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) induced a dose-dependent inhibition of 5-HT neuronal firing which could be reversed by the selective 5-HT1A antagonist N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]ethyl]-N-(2-pyridinyl)cyclohexane carboxamide (WAY 100635). Both strains were equally sensitive to 8-OH-DPAT (ED50 similar to 6.3 mu g/kg i.v,), but the mutants were less sensitive than wild-type animals to citalopram (ED50 = 0.49 +/- 0.02 and 0.28 +/- 0.01 mg/kg i.v., respectively, P < 0.05). This difference could be reduced by pretreatment of wild-type mice with the 5-HT1B/1D antagonist 2'-methyl-4'-(5-methyl-[1,2,4]oxadiazol-3-yl)-biphenyl-4-carboxylic acid [4-methoxy-3-(4-methyl-piperazine-1-yl)-phenyl]amide (GR 127935), and might be accounted for by the lack of 5-HT1B receptors and a higher density of 5-HT reuptake sites (specifically labelled by [H-3]citalopram) in 5-HT1B-/- mice. In wild-type but not 5-HT1B-/- mice, the 5-HT1B agonists 3-(1,2,5,6-tetrahydro-4-pyridyl)-5-propoxypyrrolo[3,2-b]pyridine (CP 94253, 3 mg/kg i.v.) and 5-methoxy-3-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole (RU 24969, 0.6 mg/kg i,v.) increased the firing rate of 5-HT neurons (+22.4 +/- 2.8% and +13.7 +/- 6.0%, respectively, P < 0.05), and this effect could be prevented by the 5-HT1B antagonist GR 127935 (1 mg/kg i.v.). Altogether, these data indicate that in the mouse, the firing of 5-HT neurons in the dorsal raphe nucleus is under both an inhibitory control through 5-HT1A receptors and an excitatory influence through 5-HT1B receptors.
引用
收藏
页码:3823 / 3831
页数:9
相关论文
共 37 条
[1]  
[Anonymous], 2005, CELL MOL NEUROBIOL, DOI DOI 10.1007/s10571-005-3061-z
[2]  
ARBORELIUS L, 1995, N-S ARCH PHARMACOL, V352, P157
[3]   MODIFICATION OF 5-HT NEURON PROPERTIES BY SUSTAINED ADMINISTRATION OF THE 5-HT1A AGONIST GEPIRONE - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
BLIER, P ;
DEMONTIGNY, C .
SYNAPSE, 1987, 1 (05) :470-480
[4]   THE MOUSE 5-HYDROXYTRYPTAMINE(1B) RECEPTOR IS LOCALIZED PREDOMINANTLY ON AXON TERMINALS [J].
BOSCHERT, U ;
AMARA, DA ;
SEGU, L ;
HEN, R .
NEUROSCIENCE, 1994, 58 (01) :167-182
[5]   EFFECTS OF A SELECTIVE 5-HT REUPTAKE BLOCKER, CITALOPRAM, ON THE SENSITIVITY OF 5-HT AUTORECEPTORS - ELECTROPHYSIOLOGICAL STUDIES IN THE RAT-BRAIN [J].
CHAPUT, Y ;
DEMONTIGNY, C ;
BLIER, P .
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1986, 333 (04) :342-348
[6]   EVIDENCE THAT 5-HYDROXYTRYPTAMINE RELEASE IN RAT DORSAL RAPHE NUCLEUS IS CONTROLLED BY 5-HT1A, 5-HT1B AND 5-HT1D AUTORECEPTORS [J].
DAVIDSON, C ;
STAMFORD, JA .
BRITISH JOURNAL OF PHARMACOLOGY, 1995, 114 (06) :1107-1109
[7]   IN-SITU HYBRIDIZATION EVIDENCE FOR THE SYNTHESIS OF 5-HT1B RECEPTOR IN SEROTONINERGIC NEURONS OF ANTERIOR RAPHE NUCLEI IN THE RAT-BRAIN [J].
DOUCET, E ;
POHL, M ;
FATTACCINI, CM ;
ADRIEN, J ;
ELMESTIKAWY, S ;
HAMON, M .
SYNAPSE, 1995, 19 (01) :18-28
[8]  
Fletcher A, 1996, BEHAV BRAIN RES, V73, P337
[9]  
Franklin KBJ., 1996, MOUSE BRAIN STEREOTA
[10]   Effects of sleep deprivation on serotonergic neuronal activity in the dorsal raphe nucleus of the freely moving cat [J].
Gardner, JP ;
Fornal, CA ;
Jacobs, BL .
NEUROPSYCHOPHARMACOLOGY, 1997, 17 (02) :72-81